Grass pollen allergy

The FDA ( Food and Drug Administration ) has approved Oralair, the first immunotherapy tablet to be available in the...


Grastek is an allergen extract for the treatment of grass pollen-induced allergic rhinitis with or without conjunctivitis. The efficacy of...


The FDA ( Food and Drug Administration ) has approved Grastek ( Timothy Grass Pollen Allergen Extract ) tablet for...


An important subpopulation in allergic rhinitis is represented by patients with severe form of disease that is not responsive to...


Seasonal allergic rhinoconjunctivitis affects millions of persons. The efficacy of allergen sublingual immunotherapy ( SLIT ) was demonstrated in previous...


The Fda ( Food and Drug Administration ) has approved Singulair ( Montelukast ) for the relief of symptoms of...